All In Biotech

Drug Trial Radar · NCT06786338

A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases

A Phase 2, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of SGB-9768 in Patients With Primary IgA Nephropathy, C3 Glomerulopathy, and Immune Complex-mediated Membranoproliferative Glomerulonephritis.

Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

45

Actual

Start

Jun 6, 2025

Primary completion

Dec 29, 2026

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Suzhou Sanegene Bio Inc.Industry
Sponsor type
Industry
First posted
Jan 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study looks at how well and safely SGB-9768 works for patients with certain kidney diseases: primary IgA nephropathy, C3 glomerulopathy, and immune complex-related membranoproliferative glomerulonephritis. It's a phase 2 trial done at several locations where both patients and doctors know what treatment is being given.

Conditions

  • IgA Nephropathy (IgAN)
  • C3 Glomerulopathy
  • IC-MPGN

Interventions

  • SGB-9768Drug

    SGB-9768 for subcutaneous (SC) injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. change from baseline in urine protein-creatinine ratio (UPCR)Time frame: 24 weeks

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Peking University First Hospital

    Beijing, China

  • Peking University People's Hospital

    Beijing, China

  • The Third Xiangya Hospital of Central South University

    Changsha, China

  • Sichuan Provincial People's Hospital

    Chengdu, China

  • Guizhou Provincial People's Hospital

    Guiyang, China

  • The affiliated hospital of Guizhou medical university

    Guiyang, China

  • The first affiliated hospital, Zhejiang university school of medicine

    Hangzhou, China

  • Huashan hospital

    Shanghai, China

  • Northern Jiangsu People's Hospital

    Yangzhou, China

  • General hospital of ningxia medical university

    Yinchuan, China

  • Henan Provincial People's Hospital

    Zhengzhou, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.